InvestorsHub Logo
Followers 27
Posts 744
Boards Moderated 0
Alias Born 07/12/2012

Re: vinmantoo post# 268910

Sunday, 07/24/2016 8:02:06 PM

Sunday, July 24, 2016 8:02:06 PM

Post# of 345784
Adjunctive chemo or adjunctive hormonal


therapy, either way, you have no evidence for enhancing your solo I/O 1.0 downstream inhibitors with adjunctive approaches. There's just no evidence.

Those studies may be pending, but so are the Bavi studies with NCCN, MSK and AZN. And they're much closer to starting.

We all need to take a step back once a week and consider our options. If we believe enhancement of I/O 1.0 downstream inhibitors with adjunctive agents is the way forward, it would be best to sell PPHM and move on.









Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News